Skip to main content

Dimethyl fumarate (Tecfidera): MS Clinical Trials

6 active trials · 3 recruiting

6 active multiple sclerosis clinical trials involve Dimethyl fumarate (Tecfidera), 3 currently recruiting. The list is matched on the interventions registered at ClinicalTrials.gov, so it includes head-to-head comparisons and studies where this therapy is the comparator as well as the treatment under test.

Trial results are not treatment advice: whether a therapy is right for you depends on your type of MS, disease activity and history, which is a conversation for your neurologist.

Active Dimethyl fumarate (Tecfidera) MS trials

Recruiting

A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

Sponsor: Novartis Pharmaceuticals
ofatumumab · glatiramer acetate
800 participantsDetails ›
Recruiting

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

Sponsor: Biogen
Diroximel Fumarate · Avonex
2 states908 participantsDetails ›
By invitation only

Relationship Between Oral DMT Burden and Adherence in MS

Sponsor: Monash University
Cladribine · Dimethyl fumarate
323 participantsDetails ›
Closed to new patients

A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)

Sponsor: Biogen
Diroximel Fumarate · Dimethyl Fumarate
1 state10500 participantsDetails ›
Closed to new patientsNA

Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

Sponsor: Johns Hopkins University
Natalizumab/natalizumab-sztn, Alemtuz… · Glatiramer acetate, Interferons (intr…
28 states900 participantsDetails ›

MS trials by therapy

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play